Elegant evidence in this regard was provided by experiments based on silencing TGFβ gene expression in megakaryocytes; this was found to result in the silencing of TGFβ expression in blood platelets, which partially protects from the development of cardiac hypertrophy [6]. The gene discussed is TGFB1; the disease is cardiac hypertrophy.